Stock Ratings / Industrials / DBD / options

PBI (63) VYX (32) NATL (55) PAR (31) ⌘ Pro Terminal →

Diebold Nixdorf Incorporated (DBD) Options Positioning, Max Pain & Unusual Sweeps

Q: Where is DBD trading relative to its 50-day, 200-day, and 52-week technical levels?

DBD last traded at $55.05 (-6.92% on volume of 740,002 shares), positioning the stock -14.86% below its 50-day simple moving average ($64.66) and -26.44% below its 200-day simple moving average ($74.84). Across its 52-week range of $52.87 to $92.08, DBD sits at the 5.6% percentile with a 14-day RSI of 33.5 (NEUTRAL RANGE) and an implied next-earnings move of ±8.5% ($50.37 to $59.73).

Q: What is DBD's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for DBD.

$55.05 -6.92% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $54.26

Diebold Nixdorf Incorporated (DBD) carries a Roarable Rating of D (Sell) with 51/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 51/100 (D) historically posted market-perform odds over rolling 90-day windows (-1.3% avg 90D alpha vs SPY) →

ROARABLE D • SELL / AVOID Cap $1.85B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on DBD Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is DBD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Diebold Nixdorf Incorporated (NYSE: DBD) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 51/100 at a spot price of $55.05 (-6.92% 1D, market cap $1.85B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 16/20. Across 485 tracked Industrials issuers, DBD ranks #210 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does DBD compare to PBI and VYX in the Industrials sector?

▼

Within the Industrials sector (Office Equipment/Supplies/Services), DBD carries a Roarable D (51/100 RQD), trailing P/E of 21.0x, gross margin of 25.3%, and ROIC of 11.5%. By comparison, PBI (Pitney Bowes Inc.) holds a C grade (63/100 RQD, P/E 15.6x, ROIC —, cap $2.21B) and VYX (NCR Voyix Corporation) posts a E grade (32/100 RQD, P/E 18.3x, ROIC 1.1%, cap $1.17B). Among the 5-stock peer group, PBI leads on earnings multiple (15.6x) while NATL leads on capital efficiency (14.4% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for DBD?

▼

Per DBD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000028823), Diebold Nixdorf Incorporated generated $3.81B in revenue (+1.5% YoY), $94.6M in net income, and $300.7M in free cash flow against $3.85B in total assets and $938.5M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $54.26 (-1.44%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 7.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 51/100 (D) historically posted market-perform odds over rolling 90-day windows (-1.3% avg 90D alpha vs SPY • 49.7% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-3.1% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for DBD)Realized 20D OHLCV Swing Band: ±8.5%

Deterministic 5-Pillar Attribution (51/100 Composite)

🔍 WHY DBD SCORES 51/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Insider Conviction & Share Dilution+16/20 pts (31% of score)

SEC Form 4 / 13F Thermometer: 80% Net Buy • Cannibal Buyback (-2.36% YoY Shares)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+12/20 pts (24% of score)

Altman Z-Score 1.79 (DISTRESS RISK (<1.8)) • Piotroski F-Score 8/9

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$65.19+4.1% Next Q

Q2 (-2Q)

Grade C$67.84-1.7% Next Q

Q3 (-1Q)

Grade C-$66.68-17.4% Next Q

Current

Grade D$55.05-1.3% Hist 90D α

Trajectory: C (59) → D (51)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a DBD Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While DBD currently carries a cautious 51/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Company leadership has skin in the game with net positive insider conviction.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($64.66) and Max Pain ($57.80) forces dealer call-delta covering toward $96.68.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-2.36% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $DBD• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “DBD Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 51%NO 49%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±8.5%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (DBD)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for DBD.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring DBD)

✓Walkthrough of DBD's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

DBD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -28.15%🛡️ HOLDING TREND SUPPORT

2026-11-03O $59.14H $59.14L $55.05C $55.05VOL 740.0K

RES: $105.8SUP: $52.32SMA50: $64.66SMA200: $74.84

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

DBD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 DBD Butterfly Map → + Track DBD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

14.6%/yr Implied 5Y Growth

vs. +1.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on DBD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for DBD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for DBD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DBD)

Industrials Rank #210 of 485 ⚔️ PBI vs DBD Full Matrix →

1. Head-to-Head Industrials Peer Comparison (DBD vs. PBI, VYX, NATL, PAR)

Industry: Office Equipment/Supplies/Services (13 Tracked Issuers)

Across 485 tracked Industrials securities in the Roarable RQD universe, Diebold Nixdorf Incorporated (DBD) ranks #210 by composite RQD confidence (51/100, grade D) and #214 by equity capitalization ($1.85B). Within this direct 5-issuer industry benchmark cohort, PBI leads on earnings valuation at 15.6x trailing P/E, while NATL leads on capital efficiency and profitability with 14.4% ROIC and — gross margin. PBI currently holds the highest overall quantitative score in the immediate peer group at 63/100 (C) compared with DBD at 51/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
DBD ACTIVE Diebold Nixdorf Incorporated	D	51/100	21.0x	25.3%	11.5%	-6.92%	$1.85B	Benchmark Subject
PBI Pitney Bowes Inc.	C	63/100	15.6x	—	—	-0.91%	$2.21B	/pbi-vs-dbd →
VYX NCR Voyix Corporation	E	32/100	18.3x	—	1.1%	+3.16%	$1.17B	/vyx-vs-dbd →
NATL NCR Atleos Corporation	D+	55/100	20.9x	—	14.4%	+0.24%	$3.39B	/natl-vs-dbd →
PAR PAR Technology Corporation	E	31/100	—	43.5%	-4.9%	-0.73%	$730.9M	/par-vs-dbd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2024–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000028823

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Diebold Nixdorf Incorporated (DBD) reported GAAP revenue of $3.81B (+1.5% vs. FY2024 revenue of $3.75B ) , GAAP net income of $94.6M, operating cash flow of $300.7M, and free cash flow of $300.7M (+101.5% YoY). On the balance sheet, DBD closed FY2025 with $3.85B in total assets against $938.5M in total debt (Altman Z-Score: 1.79, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$3.81B	$94.6M	$300.7M	$300.7M	$3.85B	$938.5M
FY2024 (FY)	2024-12-31	$3.75B	-$16.5M	$149.2M	$149.2M	$3.54B	$927.3M

3. DBD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is DBD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does DBD compare to PBI and VYX in the Industrials sector?

What are the biggest fundamental strengths and SEC risk factors for DBD?

Where is DBD trading relative to its 50-day, 200-day, and 52-week technical levels?

DBD last traded at $55.05 (-6.92% on volume of 740,002 shares), positioning the stock -14.86% below its 50-day simple moving average ($64.66) and -26.44% below its 200-day simple moving average ($74.84). Across its 52-week range of $52.87 to $92.08, DBD sits at the 5.6% percentile with a 14-day RSI of 33.5 (NEUTRAL RANGE) and an implied next-earnings move of ±8.5% ($50.37 to $59.73).

DBD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is DBD's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for DBD.

Direct Sub-Reports: DBD RQD Cockpit DBD 12M Forecast DBD Earnings & Move DBD Dividends & DRIP DBD Insiders & 13F DBD Whale Options DBD Profit Sankey DBD News & Why

ROARABLE RATING BRIEF • RQD 51/100 (D) ✓ STAGE-C NUMBER FIREWALL VERIFIED

DBD — Diebold Nixdorf Incorporated: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:27:05Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, DBD scores 52 out of 100, a D+ grade with the verdict "Roarable Sell — Weak Fundamentals / Trim." The five pillars are: Fundamental Cash Engine at 11/20 (ROIC 11.5%; FCF yield 15.14%), Whale 13F Flow at 4/20 (institutional accumulation and options positioning), Insider Conviction at 16/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 9/20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 12/20 (Altman Z 1.79; Piotroski F 8/9; Debt/Equity 0.85). For a prospective investor, the upside case rests mainly on the cash-generation metrics and the insider-flow pillar, which score comparatively better. The weakest pillar is institutional flow, which scores 4 of 20, meaning the 13F data offers little support for the thesis. Valuation tradeoffs are visible in the market data: trailing P/E of 21 and forward P/E of 19.5 sit alongside an operating margin of 6.4% and a net margin of 2.5%, so the reported FCF yield of 15.14% is not matched by strong earnings conversion in the income statement. The combined rating points to a cautious stance rather than an endorsement.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
$59.14	$1.99B	21	19.5	10.6	2.82	0%	1.0	$52.87 - $92.08	11.5%

Business

Diebold Nixdorf Incorporated is a NYSE-listed issuer in the Industrials sector, Office Equipment/Supplies/Services industry. Per the company profile, it is a publicly traded US company with a market capitalization of $2.0B. Not available in source data: the specific products, customer segments, and revenue model details.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$3805.7M	$242.0M	$94.6M	N/A	$300.7M	$368.9M	$938.5M
FY 2024	$3751.1M	$182.1M	$-16.5M	N/A	$149.2M	$296.2M	$927.3M

Per the SEC financials, revenue rose from $3751.1M in FY 2024 to $3805.7M in FY 2025, and net income moved from $-16.5M to $94.6M. Gross margin is 25.3%, operating margin 6.4%, and net margin 2.5% per the market data. ROIC is 11.5%. Per the Roarable RQD rating, the Altman Z-Score is 1.79, the Piotroski F-Score is 8/9, and Debt/Equity is 0.85. Cash of $368.9M against debt of $938.5M at FY 2025 indicates a leveraged balance sheet, though the Piotroski score signals solid financial health indicators.

Recent Catalysts & News Wire Analysis

Per the recent news feed, the catalysts are headline-level and include market-wire coverage (relative time 1h ago), a Yahoo Finance report on market upswing outperformance (GREEN, 3h ago), and Seeking Alpha coverage of the 2026 Q3 results and earnings call presentation dated 2026-10-31 (6h ago). A Seeking Alpha analysis frames the upside as dependent on converting backlog into cash (12h ago). Risk watch items are limited to the source headlines; no quantified risk events are provided. Per the Butterfly Supply-Chain Graph, the supply chain is NONE, with no butterfly links and no proprietary signals.

Open Questions

What drove the gap between FY 2024 net loss of $-16.5M and FY 2025 net income of $94.6M, and how much of that improvement is recurring?
Why is the reported FCF yield of 15.14% so high relative to the 2.5% net margin, and how does free cash flow reconcile to reported earnings?
What is the composition and maturity of the $938.5M debt load against $368.9M of cash?
What is the status of the backlog-to-cash conversion referenced in the Seeking Alpha coverage?
What institutional, insider, and analyst positioning exists beyond the aggregate pillar scores?

DBD Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Diebold Nixdorf Incorporated (DBD) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to DBD Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo! Finance Canada • 19h ago

Diebold Nixdorf, Incorporated (DBD) Stock Price, News, Quote & History

Yahoo! Finance Canada report covering Diebold Nixdorf Incorporated (DBD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 22h ago

Diebold Nixdorf, Incorporated (DBD) Beats Stock Market Upswing: What Investors Need to Know

Yahoo Finance report covering Diebold Nixdorf Incorporated (DBD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Seeking Alpha • 1d ago

Diebold Nixdorf, Incorporated 2026 Q3 - Results - Earnings Call Presentation (NYSE:DBD) 2026-10-31

Seeking Alpha report covering Diebold Nixdorf Incorporated (DBD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Here is What to Know Beyond Why Diebold Nixdorf, Incorporated (DBD) is a Trending Stock

Yahoo Finance report covering Diebold Nixdorf Incorporated (DBD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Seeking Alpha • 1d ago

Diebold Nixdorf: The Upside Depends On Converting Backlog Into Cash (NYSE:DBD)

Seeking Alpha report covering Diebold Nixdorf Incorporated (DBD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Yahoo Finance • 1d ago

Diebold Nixdorf, Incorporated (DBD) Suffers a Larger Drop Than the General Market: Key Insights

Yahoo Finance report covering Diebold Nixdorf Incorporated (DBD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Wall Street Analysts Think Diebold Nixdorf, Incorporated (DBD) Is a Good Investment: Is It?

Yahoo Finance report covering Diebold Nixdorf Incorporated (DBD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Fintel • 8h ago

Diebold Nixdorf Consensus Price Target Decreased by 13.56% to $86.70

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

DBD Bull vs. Bear Conversation Board — What's Your Call at $55.05?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON DBD 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $63.87 (+8.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is DBD (D+ • RQD 52/100) a Buy at $59.14?

Welcome to the DBD (Diebold Nixdorf Incorporated) Roar Pit. Current RQD Composite is 52/100 (Roarable Sell — Weak Fundamentals / Trim) in Office Equipment/Supplies/Services. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

BE BearTrap_Alert Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $48.49 (-18.0%)

Spot @ $59.14

Pump the brakes on DBD — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on DBD, but look at what you are paying: 21.0x trailing P/E with 25.3% gross margins. Unless Diebold Nixdorf Incorporated expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

SI SiliconVal_Bull Verified K Arena Trader 🐂 BULLISH 🎯 Target: $68.60 (+16.0%)

Spot @ $59.14

DBD cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on DBD, the market is fixating on short-term headline noise in Office Equipment/Supplies/Services and ignoring the balance sheet and cash flow trajectory. At $59.14 (52-wk range $52.87 - $92.08), any beat on forward guidance forces shorts and underweight funds to chase.